Phedias Diamandis - Publications

Affiliations: 
University Health Network, Toronto, Ontario, Canada 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sajid RS, van Winden LJ, Diamandis P. Towards deciphering glioblastoma intra-tumoral heterogeneity: The importance of integrating multidimensional models. Proteomics. e2200401. PMID 37488996 DOI: 10.1002/pmic.202200401  0.464
2023 Paliwal A, Faust K, Alshoumer A, Diamandis P. Standardizing analysis of intra-tumoral heterogeneity with computational pathology. Genes, Chromosomes & Cancer. 62: 526-539. PMID 37067005 DOI: 10.1002/gcc.23146  0.357
2022 Lam KHB, Diamandis P. Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup. Scientific Data. 9: 596. PMID 36182941 DOI: 10.1038/s41597-022-01716-5  0.341
2022 Lam KHB, Faust K, Yin R, Fiala C, Diamandis P. The Brain Protein Atlas: A conglomerate of proteomics datasets of human neural tissue. Proteomics. 22: e2200127. PMID 35971647 DOI: 10.1002/pmic.202200127  0.322
2022 Melliou S, Sangster KT, Kao J, Zarrei M, Lam KHB, Howe J, Papaioannou MD, Tsang QPL, Borhani OA, Sajid RS, Bonnet C, Leheup B, Shannon P, Scherer SW, Stavropoulos DJ, ... ... Diamandis P, et al. Regionally defined proteomic profiles of human cerebral tissue and organoids reveal conserved molecular modules of neurodevelopment. Cell Reports. 39: 110846. PMID 35613588 DOI: 10.1016/j.celrep.2022.110846  0.378
2022 Dent A, Diamandis P. Integrating computational pathology and proteomics to address tumor heterogeneity. The Journal of Pathology. PMID 35373360 DOI: 10.1002/path.5905  0.313
2022 Lam KHB, Leon AJ, Hui W, Lee SC, Batruch I, Faust K, Klekner A, Hutóczki G, Koritzinsky M, Richer M, Djuric U, Diamandis P. Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity. Nature Communications. 13: 116. PMID 35013227 DOI: 10.1038/s41467-021-27667-w  0.475
2021 Melliou S, Sangster KT, Djuric U, Diamandis P. The promise of organoids for unraveling the proteomic landscape of the developing human brain. Molecular Psychiatry. 27: 73-80. PMID 34703024 DOI: 10.1038/s41380-021-01354-0  0.362
2021 Samuel N, So E, Djuric U, Diamandis P. Consumer-grade electroencephalography devices as potential tools for early detection of brain tumors. Bmc Medicine. 19: 16. PMID 33478449 DOI: 10.1186/s12916-020-01889-z  0.307
2020 Papaioannou MD, Sangster K, Sajid RS, Djuric U, Diamandis P. Cerebral organoids: emerging ex vivo humanoid models of glioblastoma. Acta Neuropathologica Communications. 8: 209. PMID 33261657 DOI: 10.1186/s40478-020-01077-3  0.4
2020 Selvadurai HJ, Luis E, Desai K, Lan X, Vladoiu MC, Whitley O, Galvin C, Vanner RJ, Lee L, Whetstone H, Kushida M, Nowakowski T, Diamandis P, Hawkins C, Bader G, et al. Medulloblastoma Arises from the Persistence of a Rare and Transient Sox2 Granule Neuron Precursor. Cell Reports. 31: 107511. PMID 32294450 DOI: 10.1016/J.Celrep.2020.03.075  0.565
2019 Karimi S, Zuccato JA, Mamatjan Y, Mansouri S, Suppiah S, Nassiri F, Diamandis P, Munoz DG, Aldape KD, Zadeh G. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Clinical Epigenetics. 11: 185. PMID 31806041 DOI: 10.1186/S13148-019-0766-2  0.317
2019 Sikpa D, Fouquet JP, Lebel R, Diamandis P, Richer M, Lepage M. Automated detection and quantification of breast cancer brain metastases in an animal model using democratized machine learning tools. Scientific Reports. 9: 17333. PMID 31758004 DOI: 10.1038/S41598-019-53911-X  0.333
2019 Grenier K, Kao J, Diamandis P. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age. Molecular Psychiatry. PMID 31444473 DOI: 10.1038/s41380-019-0500-7  0.338
2019 Papaioannou MD, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P. Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns. Neuro-Oncology. PMID 31077268 DOI: 10.1093/Neuonc/Noz084  0.312
2017 Diamandis P, Aldape KD. Insights From Molecular Profiling of Adult Glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 2386-2393. PMID 28640696 DOI: 10.1200/JCO.2017.73.9516  0.399
2016 Diamandis P, Ferrer-Luna R, Huang RY, Folkerth RD, Ligon AH, Wen PY, Beroukhim R, Ligon KL, Ramkissoon SH. Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma. Diagnostic Pathology. 11: 13. PMID 26817999 DOI: 10.1186/S13000-016-0455-9  0.331
2009 Diamandis P, Sacher AG, Tyers M, Dirks PB. New drugs for brain tumors? Insights from chemical probing of neural stem cells. Medical Hypotheses. 72: 683-7. PMID 19261391 DOI: 10.1016/J.Mehy.2008.10.034  0.682
2007 Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB. Chemical genetics reveals a complex functional ground state of neural stem cells. Nature Chemical Biology. 3: 268-73. PMID 17417631 DOI: 10.25011/Cim.V31I4.4797  0.51
Show low-probability matches.